Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 169
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can albumin from egg whites be used to treat Clostridium difficile infections?

Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections and...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

T Cell Vaccines as an Immunotherapy for Type 1 Diabetes

Type 1 Diabetes develops when CD4+ T cells aren't taught to differentiate between self-antigens and foreign...

Backer Badge Funded